Entity
Description
  • Value proposition

    Code the body can run.

    BIOS Health uses AI-driven insights from the nervous system to build neural digital therapies - the next big trend in precision medicines. The human nervous system carries vast quantities of data, and BIOS’ ability to precisely link nerve activity to specific conditions through the discovery of their neural biomarkers is a game changer for precision medicine. BIOS’ research could hold the key to new treatments for conditions including hypertension, diabetes, rheumatoid arthritis, and even diseases of the brain itself such as Parkinson’s or Alzheimer’s. BIOS is positioned to provide the neural code on which a new generation of treatments can be built that can enable millions of people suffering from chronic diseases to improve their quality of life.

    Co-founded by Cambridge University researchers Emil Hewage, a computational neuroscientist, and Oliver Armitage, a biomechanical engineer, BIOS is made up of a wide range of experts from neuroscience, machine learning, software engineering, applied biomaterials, biotechnology, medicine, and business and operations. The combined experience of the BIOS team extends to over 300 peer-reviewed publications, 10+ first of kind medical devices, and 6k+ clinical procedures.

    We are looking for people who will fit into our diverse, fun and stimulating company team culture, who are focused on overcoming challenges, and want to grow along with the company. We are especially looking for candidates that share our values: enjoy solving hard problems; bring a unique perspective but become an active part of the BIOS team; respect what matters and do what’s right; and enjoy the challenge.

    artificial intelligence , data, neurotech, and neural engineering

  • Neural Engineering | BIOS Health | United Kingdom

    BIOS Health is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals. Beginning with cardiac conditions, BIOS envisions a new field of digital health treatments that use this new data-driven insight from the nervous system to create personalised, precision medicine.

  • https://www.bios.health/
Corporate interactions BETA
Corporate TypeTweets Articles
Illumina For Startups
Illumina For Startups
Startup accelerator & VC, Biotechnology, Biotechnology Research
Illumina For Startups
Startup accelerator & VC, Biotechnology, Biotechnology Research
Other

12 Jan 2016


Hewlett Packard Enterprise
Hewlett Packard Enterprise
Consulting, audit, IT Services and IT Consulting
Hewlett Packard Enterprise
Consulting, audit, IT Services and IT Consulting
Other

31 Jan 2016


Cisco
Cisco
IT services, Software Development
Cisco
IT services, Software Development
Other

7 Sep 2016


Volvo Cars
Volvo Cars
Automobile, Motor Vehicle Manufacturing
Volvo Cars
Automobile, Motor Vehicle Manufacturing
Not capitalistic
Not partnership
Event

23 Sep 2016


KPMG
KPMG
Consulting, audit, Accounting
KPMG
Consulting, audit, Accounting
Not capitalistic
Not partnership
Event

8 Mar 2018


AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Not capitalistic
Partnership
Event

11 May 2018

21 Sep 2023



ServiceNow Research
ServiceNow Research
IT services, Research, Research Services
ServiceNow Research
IT services, Research, Research Services
Not capitalistic
Not partnership
Event

30 May 2018


Microsoft
Microsoft
IT services, Software Development
Microsoft
IT services, Software Development
Other

21 Dec 2018


Allia Ltd
Allia Ltd
Non-profit Organizations
Allia Ltd
Non-profit Organizations
Not capitalistic
Not partnership
Event

7 Mar 2019


Cambridge Enterprise
Cambridge Enterprise
Startup accelerator & VC, Higher Education
Cambridge Enterprise
Startup accelerator & VC, Higher Education
Not capitalistic
Partnership
Event

11 Mar 2019


Similar entities
Loading...
Loading...
Social network dynamics